0
0
OptimumLogin
http://missiontherapeutics.com/wp-content/uploads/2017/04/mission-therapeutics-web-1.png
OptimumLogin2016-02-02 08:18:472016-02-02 08:18:47MISSION Therapeutics Raises £60 million to Progress Development of Novel DUB Inhibitors from Innovative Drug Platform
0
0
OptimumLogin
http://missiontherapeutics.com/wp-content/uploads/2017/04/mission-therapeutics-web-1.png
OptimumLogin2015-10-01 08:05:302015-10-01 08:05:30MISSION Therapeutics appoints David Luther as Chief Financial Officer
0
0
OptimumLogin
http://missiontherapeutics.com/wp-content/uploads/2017/04/mission-therapeutics-web-1.png
OptimumLogin2015-09-22 14:02:402015-09-22 14:02:40MISSION Therapeutics receives funding from Innovate UK for DUB cancer programme
0
0
OptimumLogin
http://missiontherapeutics.com/wp-content/uploads/2017/04/mission-therapeutics-web-1.png
OptimumLogin2015-09-01 09:00:252015-09-01 09:00:25MISSION Therapeutics appoints Michael Koslowski as Chief Medical Officer
0
0
OptimumLogin
http://missiontherapeutics.com/wp-content/uploads/2017/04/mission-therapeutics-web-1.png
OptimumLogin2015-07-01 14:45:032015-07-01 14:45:03MISSION appoints Dr Colin Goddard to its Board of Directors
0
0
OptimumLogin
http://missiontherapeutics.com/wp-content/uploads/2017/04/mission-therapeutics-web-1.png
OptimumLogin2015-06-11 14:48:312015-06-11 14:48:31Prof Steve Jackson to give Sackler Lecture
Scroll to top
